optional text

ALPHASENSE EXPERT BRIEFING SERIES PRESENTS:

The Great Vaccine Race

As the reported COVID-19 death toll approaches 1 million globally, all eyes are on the multibillion dollar race for a vaccine. Carter Gould, U.S. Biopharma Analyst at Barclays, will discuss COVID-19 vaccines and treatment options given what we know to date.

Though a number of key questions remain and the landscape is rapidly changing, Carter will synthesize the state of the vaccine race, taking into account upcoming events, timelines for trial results, hurdles to approval and distribution, and likely efficacy.

Watch this replay to gain insights on:

  • The state of the vaccine race, recent developments, and major players
  • What to expect given timelines for trial results and hurdles to approval and distribution
  • The likely efficacy of COVID-19 vaccines and treatments, and the resulting societal and market impacts

Watch the replay

Please note: For this series, we are unable to accept requests from employees of consulting and private equity firms. Regretfully, we will decline requests from these entities.

Watch the replay

Please note: For this series, we are unable to accept registration from employees of financial services and consulting firms. Regretfully, we must cancel registrations from these entities.

Lorem ipsum dolor

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

CTA

Lorem ipsum dolor

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

CTA

Lorem ipsum dolor

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

CTA

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

Lorem ipsum dolor

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

CTA

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

Lorem ipsum dolor

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

Lorem ipsum
Lorem ipsum

Lorem ipsum
Lorem ipsum

CTA

Lorem ipsum dolor sit amet

Lorem ipsum dolor

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

CTA

Lorem ipsum dolor

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

HOSTED BY


HSBC_Murat-Ulgen.jpg

Dr. Murat Ulgen

Global Head of Emerging Markets Research
HSBC

Dr. Murat Ulgen joined HSBC in April 2006 as the Chief Economist for Turkey. Before joining HSBC, he held several sell-side economist and strategist positions in London and Istanbul, covering more than 15 emerging market countries in that time zone. In December 2009, Dr. Ulgen was appointed HSBC's Chief Economist for Central & Eastern Europe and sub-Saharan Africa. Dr. Ulgen holds a doctorate degree in finance and has also lectured at several Turkish universities on economics and international finance. Dr. Ulgen was appointed HSBC's Global Head of Emerging Markets Research in June 2014.



AS_Joe-Hill.jpg

Joe Hill

Chief Financial Office
AlphaSense

Joe joined AlphaSense as CFO this February with over 25 years of international business management experience, previously having held positions as CFO and Board Member in the high-tech and bio-tech industries, including at Greenway Health, Monotype, Metabilox, Inc., AMICAS, Inc. and other world class organizations.










LEARN MORE ABOUT WALL STREET INSIGHTS

Product_Screen-Equity-Research.png

Wall Street Insights: Premium Equity Research

Explore the first and only premium equity research collection purpose-built for the corporate market. Tap into market-leading research from Morgan Stanley, Bank of America and 1,000+ other brokers.

Resource-Tile_Trial_WSI.png

Unlock Access to Market-Leading Research

Gain unprecedented access to a deep pool of insights -- and the AI search tools you need to extract value. New AlphaSense users can trial Wall Street Insights free of charge for two weeks.

Resource-Tile_Ebook_The-Value-of-Equity-Research.png

The Value of Equity Research: A Comprehensive Guide

Learn how the most strategic teams are leveraging deep industry research from Wall Street’s top analysts to inform critical business decisions during uncertain times.

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

CTA

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore.

CTA
CTA

SPEAKER


 

Barclays_Carter-Gould.png
      

Carter Gould, US Biopharma Analyst, Barclays
Carter Gould is a Senior Analyst covering U.S. Biopharma Equity Research at Barclays. Carter has 15+ years of biopharma experience across the sell-side, strategy consulting, and operations. He was previously recognized as an Institutional Investor Rising Star in 2017 (Large-Cap Biotech), and previously held roles at UBS and J.P. Morgan. He holds degrees in Chemistry from Johns Hopkins and the University of Chicago.





MODERATOR

 

AS_Craig-Farrell.jpeg

Craig Farrell, VP, Go-To-Market StrategyAlphaSense








Lorem ipsum dolor sit amet

CTA

Lorem ipsum dolor sit amet

CTA